Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel quaternary ammonium base catalyzed N-alkylation of 2-pyridone. High selectivity, simplified purification, ideal for API intermediates.
Patent CN110330463B reveals a high-yield route for florfenicol intermediates using thionyl chloride and potassium fluoride, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103180325A reveals high-yield beta-artemether synthesis. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical buyers.
Novel uridine-based route reduces toxicity and cost. Green manufacturing for antiviral intermediates ensuring supply chain stability.
Novel synthesis of brominated and piperazine-ring rupestonic acid esters for antiviral applications. Efficient phase-transfer catalysis route ensures high purity and scalable production for pharmaceutical partners.
Novel method eliminates toxic o-chloroaniline for Vitamin B1 intermediate synthesis, offering cost reduction and safer supply chain solutions for pharma manufacturers.
Patent CN107162970B details green synthesis of quinolinone derivatives. Offers high purity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN102363796B details a microbial fermentation method for glycyrrhetinic acid using Aspergillus flavus, offering >98% purity and sustainable supply chain advantages.
Discover high-efficiency NNN ligand metal complexes for 1,1-disubstituted alkene hydroboration. Cost-effective iron catalysis for pharmaceutical intermediates.
Patent CN105622566B reveals a cuprous salt catalyzed route for statin intermediates. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover the safer Rh-catalyzed cyclization route for beta-lactam antibiotics from CN1097424A, offering significant cost reduction and supply chain stability for pharma manufacturers.
Patent CN1077881C details a regiospecific route to cis-1-amino-2-indanol from diols or halohydrins, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for HIV protease inhibitors.
Patent CN111518108B reveals a convergent 3-step synthesis for optically pure tetrandrine, offering superior yields and scalable production for pharmaceutical supply chains.
Patent CN110028422A reveals a novel amino protection method using imidazole hydrochloride. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN1481365A reveals a novel organosilicon cyclization route for quinolones. Discover cost-effective manufacturing and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN1362960A details a Lewis acid-catalyzed cyclization for enantiomerically pure PDE4 inhibitors, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN109293554A reveals a one-step carbonylation route for N-benzyl phthalimide. This method offers mild conditions and superior yields for reliable pharmaceutical intermediate supply chains.
Patent CN109096161B reveals a novel route converting cysteine mother liquor into high-purity N-acetylcysteine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107278204B details a safer copanlisib route offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN106188097B reveals a streamlined 3-step route for oxacephem antibiotics. This report analyzes cost reduction in antibiotic manufacturing and supply chain reliability for global buyers.